Fecal calprotectin (FCP) has limited specificity as diagnostic biomarker of pediatric inflammatory bowel disease (IBD), leading to unnecessary invasive endoscopies.
This study aimed to develop and validate a fecal microbiota and amino acid (AA)-based diagnostic model.
